Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Supporters often stress the potential for meaningful therapeutic outcomes, particularly in conditions where conventional therapies have proven ineffective. However, this is to consider the substantial financial burden associated with CPI stem cell ther